In two double-blind studies with 24 and 12 patients, respectively, the effect of silymarine on chronic hepatitis was studied. The treatment lasted three months to one year. In the laboratory tests investigated no remarkable difference between silymarine and placebo therapy was seen.
View Article and Find Full Text PDFMunch Med Wochenschr
September 1971
Dtsch Med Wochenschr
August 1971
Wien Klin Wochenschr
February 1970
Virchows Arch A Pathol Pathol Anat
August 1970
Munch Med Wochenschr
November 1968
Wien Klin Wochenschr
August 1968